Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Featured Broker Partners


Advertisement